From 2025, abolish the regulation of dividing the list of health insurance drugs by hospital class
Medical facilities are allowed to use all drugs on the health insurance drug list in accordance with the scope of professional activities, regardless of the type of hospital or technical level.
The Ministry of Health has just issued Circular 37/2024/TT-BYT which outlines the principles and criteria for developing, updating, recording information, list structure and payment instructions for pharmaceutical drugs. , biological products, radioactive drugs and tracers are within the scope of Circular 37/2024/TT-BYT. benefits of health insurance participants.
This Circular regulates the principles of building and updating the list of drugs, criteria for considering drugs to be included in the list, reviewing drugs that require regulations on fees, health insurance conditions and considering removing drugs from the list. .
Providing more information about the new points of Circular 37/2024/TT-BYT, the representative of the Department of Health Insurance (Ministry of Health) emphasized that the Circular abolishes the regulation on dividing the drug list by hospital class.
It will also encourage establishments to develop skills and techniques;
In addition, the Circular also adds new regulations to the drug payment instructions.
Circular 37/2024/TT-BYT will take effect from January 1, 2025.
